The Icahn School of Medicine at Mount Sinai today announced the launch of a new center dedicated to advancing the delivery of health care through research, development, and implementation of innovative artificial intelligence tools and technologies. The Hamilton and Amabel James Center for Artificial Intelligence and Human Health in Manhattan to combine artificial intelligence with data science and genomics in a standalone site. The building will enable researchers to enhance their
Read More
Mount Sinai Appoints Andrew Kasarskis As First-Ever Chief Data Officer
Andrew Kasarskis, PhD, Chief Data Officer at Mount Sinai
Mount Sinai has appointed Andrew Kasarskis, Ph.D., an internationally recognized expert in biomedical data as the health system’s first-ever Executive Vice President and Chief Data Officer (CDO). In this new role, Dr. Kasarskis will facilitate the accessibility and sharing of clinical, financial, and administrative data, and open application development, all in support of better patient care, decision-making, and healthcare
Read More
Canadian Government Awards $49M Grant to Establish Canada-wide AI Health Data Platform
The government of Canada has announced an investment grant of up to $49 million in the Digital Health and Discovery Platform (DHDP), a network of partners that seeks to establish a cutting-edge Canada-wide health data platform. Through this new platform, researchers and doctors will work to accelerate the development of new and personalized treatments to help to find cures for diseases that affect Canadians. While the platform will initially focus on cancer, the plan is to expand to other areas
Read More
Glooko Appoints Dr. Mark Clements as Chief Medical Officer
Dr. Mark Clements, Chief Medical Officer at Glooko
Glooko, a provider of diabetes data management solutions, today announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr. Clements joins the senior management team of Glooko having served on its medical advisory board since it was formed in 2015 to provide expertise to the organization in the areas of clinical studies and diabetes analytics.
Dr. Clements comes to Glooko from the University of
Read More
HIMSS Appoints Dr. Sebastian Krolop As Global Chief Operating & Strategy Officer
Dr. Sebastian Krolop, MD
HIMSS, has announced the
appointment of Dr. Sebastian Krolop, MD, PhD, MSc, to the role of
chief operating & strategy officer (COSO). Under his leadership as COSO, Dr. Krolop will lead the alignment of HIMSS’s
operational goals with the organization’s strategic plan. In addition, he will
guide the direction of HIMSS
Analytics, HIMSS
Media and foster additional support services in international
markets.
Dr. Krolop Background/Experience
Dr.
Read More
GoCheck Kids Nabs $6M for iPhone App That Detects Amblyopia in Pre-Verbal Children
GoCheck Kids, the creators of an FDA-registered and CE certified iPhone app that screens for amblyopia in pre-verbal children used by over 4,500 pediatricians announced it has raised $6M in Series B funding led by FCA Venture Partners. The investment will be used to add artificial intelligence capabilities with Apple’s CoreML and ARKit and accelerate further electronic health record (EHR) integrations.
Amblyopia: The Leading Cause of Vision Loss in U.S. Children
According to the CDC,
Read More
4 Digital Health Adoption Barriers for Hospitals & Health Systems
Nearly two-thirds of healthcare providers rate themselves as being behind the curve on their digital health adoption initiatives, according to new research from Unisys Corporation. On behalf of Unisys, HIMSS surveyed 220 health IT decision makers/influencers at U.S. hospitals and health systems and asked them to rank their organization based on how they are leveraging digital and mobile technologies to improve the patient experience, lower the cost of care delivery and improve clinician/staff
Read More
HealthQuest Capital Closes $440M Fund to Invest in Innovative Growth-Stage Companies
HealthQuest Capital, a Silicon Valley-based growth capital firm has closed a $440 million fund to invest growth-stage companies delivering innovation across all sectors of the healthcare industry to improve patient outcomes, enhance efficiency and reduce costs. Fund III was oversubscribed and closed at a hard cap. Target markets for Fund III include growth- and commercial-stage companies focusing on medical technologies, diagnostics, digital health, and innovative services.HealthQuest Capital
Read More
Mount Sinai Researchers Crowdsource Gene Expression Data for Drug & Target Discovery
Researchers at the Icahn School of Medicine at Mount Sinai have crowdsourced the annotation and analysis of a large number of gene expression profiles from the National Center for Biotechnology Information’s (NCBI) Gene Expression Omnibus (GEO). For the project, more than 70 volunteers from 25 countries helped Mount Sinai researchers analyze the data, enabling the identification of new associations between genes, diseases, and drugs – something that a smaller number of unaided researchers, or an
Read More
Infographic: 40 Key Trends Shaping The Future of Medicine
What is the future of medicine? Currently, there is a revolution of changes driven by healthcare reform initiatives, rising healthcare costs and technology.
Read More